Followup of the Ratingener Rheumakohorte initiated by Rolf Rau

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00009454

Enrollment

105

Registered

2016-04-18

Start date

2015-08-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis M06.99

Interventions

Group 1: Methotrexate 15-25mg/week, i.v. or i.m, later switch to p.o possible. Examination 30 years after baseline: Swollen, tender joint count as well as deformities (out of 38), patient global asses

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: therapy with Methotrexate in the 1980s

Exclusion criteria

Exclusion criteria: no Methotrexate-therapy

Design outcomes

Primary

Measure	Time frame
Calculation of mortality and standardized mortality ratios. Date of evaluation: 30 years after baseline.	—

Secondary

Measure	Time frame
Evaluation of disease activity and patient global assessment via Hannover questionnaire. Determination of swollen and tender joint count as well as deformities. Date of evaluation: 30 years after baseline.	—

Countries

Germany

Contacts

Public ContactDietmar Krause

Ruhr-Uni Bochum

Gundi.Krause@t-online.de0204320610

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026